A phase II trial of pembrolizumab in combination with cisplatin or carboplatin and etoposide in chemotherapy naive patients with metastatic or unresectable high-grade gastroenteropanncreatic or lung neuroendocrine carcinoma.
Document Type
Article
Publication Date
2-4-2020
Publication Title
Journal of clinical oncology
Volume
38(4 Suppl)
Recommended Citation
Ramirez, Robert A.; Matrana, Marc Ryan; Satti, Suma; Griffin, Ryan Patrick; Voros, Brianne A.; and Bren-Mattison, Yvette, "A phase II trial of pembrolizumab in combination with cisplatin or carboplatin and etoposide in chemotherapy naive patients with metastatic or unresectable high-grade gastroenteropanncreatic or lung neuroendocrine carcinoma." (2020). School of Medicine Faculty Publications. 1789.
https://digitalscholar.lsuhsc.edu/som_facpubs/1789
10.1200/JCO.2020.38.4_suppl.TPS635
COinS